INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19
PLYMOUTH MEETING, Pa., Dec. 7, 2020 /PRNewswire/ — INOVIO (NASDAQ: INO), a biotechno...
Amazon Just Put 23andMe's Ancestry DNA Kit On Sale For Only $79
23andMe’s Ancestry Kit is on sale on Amazon ...
How to protect your DNA for big health benefits
(HealthDay)—You might think that stress affects ...
James Watson, Co-Discoverer of DNA Structure, Stripped of Honors Over Racist Statements
James Watson co-discovered the double-helix struct...
